APONVIE Trademark

Trademark Overview

On Friday, October 1, 2021, a trademark application was filed for APONVIE with the United States Patent and Trademark Office. The USPTO has given the APONVIE trademark a serial number of 97056540. The federal status of this trademark filing is REGISTERED as of Tuesday, May 30, 2023. This trademark is owned by Heron Therapeutics, Inc.. The APONVIE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing scientific and medical research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development services; product research and development services
aponvie

General Information

Serial Number97056540
Word MarkAPONVIE
Filing DateFriday, October 1, 2021
Status700 - REGISTERED
Status DateTuesday, May 30, 2023
Registration Number7069700
Registration DateTuesday, May 30, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements

Goods and ServicesProviding scientific and medical research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development services; product research and development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code042
First Use Anywhere DateThursday, March 2, 2023
First Use In Commerce DateThursday, March 2, 2023

Trademark Owner History

Party NameHeron Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US
Party NameHeron Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US
Party NameHeron Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US

Trademark Events

Event DateEvent Description
Tuesday, October 5, 2021NEW APPLICATION ENTERED
Thursday, October 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 23, 2022ASSIGNED TO EXAMINER
Thursday, June 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2023ASSIGNED TO EXAMINER
Friday, February 10, 2023SOU TEAS EXTENSION RECEIVED
Friday, February 10, 2023SOU EXTENSION 1 FILED
Friday, February 10, 2023SOU EXTENSION 1 GRANTED
Tuesday, February 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 8, 2023TEAS STATEMENT OF USE RECEIVED
Friday, March 24, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 8, 2023USE AMENDMENT FILED
Friday, March 24, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 30, 2023SU - NON-FINAL ACTION - WRITTEN
Thursday, March 30, 2023NON-FINAL ACTION E-MAILED
Thursday, March 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 25, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 26, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 27, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 30, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 30, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, August 16, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

aponvie research development services pharmaceutical trials clinical product pharmaceuticals scientific medical